Medistep Healthcare IPO – Huge Investor Rush with Over 350x Subscription!

Medistep Healthcare Ltd, a Gujarat-based pharmaceutical and wellness products company, is making a strong debut in the SME segment with its ₹16.10 crore fixed-price IPO. The company manufactures sanitary pads, energy powders, and trades pharmaceuticals, nutraceuticals, surgical, and intimate-care products. The overwhelming subscription numbers and solid grey market premium (GMP) indicate high retail investor interest.

IPO Key Details

• IPO Type: Fixed Price SME IPO

• Issue Size: ₹16.10 crore (37.44 lakh shares)

• Price per Share: ₹43 (Face Value ₹10)

• Lot Size: 3,000 shares

• Retail Minimum Investment: 2 lots = 6,000 shares = ₹2,58,000

• Lead Manager: Fast Track Finsec Pvt. Ltd.

• Registrar: Cameo Corporate Services Ltd.

• Listing Exchange: NSE SME (Emerge)

IPO Timeline

Use of IPO Proceeds

1. Purchase of plant & machinery to expand manufacturing capacity

2. Working capital requirements

3. General corporate purposes

Subscription Status

• Retail Category: 461.17x

• Non-Institutional: 254.93x

• Overall Subscription: 352.93x

This level of subscription in the SME segment is a strong indicator of market confidence and potential for listing gains.

Grey Market Premium (GMP)

• Current GMP: ₹15–₹17 per share

• Expected Listing Price: ₹58–₹60 (35%–40% premium over issue price)

Financial Performance (FY25)

• Revenue: ₹49.65 crore (up from ₹39.07 crore in FY24)

• Profit After Tax (PAT): ₹4.14 crore (vs ₹3.33 crore in FY24)

• EBITDA: ₹5.60 crore

Steady revenue growth and profit increase highlight the company’s scalable business model.

How to Check Allotment Status

Investors can check allotment status through:

1. Registrar Website (Cameo Corporate Services Ltd.) – Enter PAN or Application Number.

2. NSE SME Allotment Page – Using application details.

3. Broker Platforms – Many brokers display IPO allotment results directly.

Market Impact & Investor View

The IPO’s overwhelming subscription and strong GMP signal that listing day could see robust upside movement. For short-term investors, the GMP trend is promising, while long-term investors may see potential in the company’s expansion plans and product diversification in the fast-growing healthcare & wellness sector.

💡 Analyst Note: While GMP is positive, SME stocks can be volatile post-listing. Investors should watch the stock’s delivery volumes and business updates for sustained growth.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their financial advisor before making any investment decisions.